Xiangwen Xia

Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer

Qianqian Ren, Peng Zhu, Hui Zhang et al. · Cancer Cell International · 2020 · 50 citations · Full text

Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells

Jianzhuang Ren, Chuansheng Zheng, Gansheng Feng et al. · Journal of Huazhong University of Science and Technology [Medical Sciences] · 2009 · 35 citations

Medicine, Liver Physiology, Hepatocellular Carcinoma Cells +6

Effect of Transcatheter Intraarterial Therapies on the Distribution of Doxorubicin in Liver Cancer in a Rabbit Model

Bin Liang, Fu Xiong, Han‐Ping Wu et al. · PLoS ONE · 2013 · 33 citations · Full text

<scp>NRF</scp>2/<scp>ABCB</scp>1‐mediated efflux and <scp>PARP</scp>1‐mediated dampening of <scp>DNA</scp> damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cells

Xiangwen Xia, Qi Wang, Tianhe Ye et al. · Fundamental and Clinical Pharmacology · 2019 · 24 citations · Full text

Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study

Haohao Lu, Bin Liang, Xiangwen Xia et al. · BMC Cancer · 2023 · 19 citations · Full text